Spotlight Asset Group’s Pfizer PFE Stock Holding History

Spotlight Asset Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$193K	Sell	6,886 -180	-3%	-$4.96K	0.13%	75
2024 Q1	$196K	Buy	7,066 +3,236	+84%	+$89.8K	0.14%	75
2023 Q4	$127K	Hold	3,830	–	–	0.12%	83
2023 Q3	$127K	Hold	3,830	–	–	0.12%	83
2023 Q2	$140K	Buy	+3,830	New	+$149K	0.13%	76
2021 Q3	$285K	Buy	6,621 +188	+3%	+$8.33K	0.14%	95
2021 Q2	$252K	Buy	6,433 +258	+4%	+$10K	0.1%	109
2021 Q1	$224K	Sell	6,175 -3,085	-33%	-$110K	0.08%	117
2020 Q4	$341K	Sell	9,260 -1,693	-15%	-$62.1K	0.13%	98
2020 Q3	$381K	Buy	10,953 +3,578	+49%	+$125K	0.15%	94
2020 Q2	$229K	Sell	7,375 -610	-8%	-$20.7K	0.1%	117
2020 Q1	$247K	Buy	7,985 +105	+1%	+$3.58K	0.13%	90
2019 Q4	$265K	Buy	+7,880	New	+$281K	0.13%	92

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Spotlight Asset Group's PFE Position: Q2 2024 in Review

Spotlight Asset Group reduced its Pfizer (PFE) stake by 2.5% in Q2 2024, selling an estimated $4.96K and leaving 6,886 shares worth $193K. The position accounts for 0.13% of the portfolio, ranked #75.

Spotlight Asset Group first reported a position in PFE in Q4 2019 and has held it in 13 quarters since. The position peaked at $381K in Q3 2020. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Spotlight Asset Group held 6,886 shares of Pfizer worth $193K as of Q2 2024.
Spotlight Asset Group sold 180 Pfizer shares in Q2 2024, an estimated $4.96K.
Pfizer made up 0.13% of Spotlight Asset Group's portfolio in Q2 2024, its #75 holding.
Spotlight Asset Group first reported a position in Pfizer in Q4 2019 and has held it in 13 quarters since.
Spotlight Asset Group's Pfizer position peaked at $381K in Q3 2020.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Spotlight Asset Group's 13F filing for Q2 2024, filed 24 Jul 2024.